Preoperative Prevention of Heart Failure in Noncardiac Surgery
Congestive heart failure is consistently associated with adverse outcomes, and is characterized by a twofold increase in mortality in noncardiac surgery. In this regard, developing the methods aimed to prevent and treatacute heart failure (AHF) in the intraoperative period remain a challenging probl...
Saved in:
| Main Authors: | V. V. Likhvantsev, Yu. V. Ubasev, Yu. V. Skripkin, T. S. Zabelina, V. A. Sungurov, V. V. Lomivorotov, D. N. Marchenko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia
2016-07-01
|
| Series: | Общая реаниматология |
| Subjects: | |
| Online Access: | https://www.reanimatology.com/rmt/article/view/1530 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
POSITIVE IMPACT OF INFUSION WITH LEVOSIMENDAN ON THE ELDER PATIENTS (60-75 YEARS OLD) WITH LOWER EJECTION FRACTION OF THE LEFT VENTRICLE (< 50%) IN THE PERI-OPERATIVE PERIOD IN NON-CARDIAC SURGERY
by: Yu. V. Ubasev, et al.
Published: (2018-01-01) -
PREVENTION OF HEART FAILURE IN NON-CARDIAC SURGERY WITH THE LOWER EJECTION FRACTION OF LEFT VENTRICULAR: LEVOSIMENDAN OR ANESTHETIC CARDIOPROTECTION? (randomized multi-centered trial)
by: V. V. Likhvantsev, et al.
Published: (2018-01-01) -
Perioperative Predictors of Unfavorable Outcome of Vascular Surgery
by: Viktor V. Moroz, et al.
Published: (2017-06-01) -
The Use of Levosimendan for the Treatment of Heart Failure and its Potential Organoprotective Effects
by: N. B. Lebedeva, et al.
Published: (2022-05-01) -
LEVOSIMENDAN IN PREOPERATION THERAPY FOR CARDIOSURGERY IN PATIENTS WITH CHRONIC HEART FAILURE
by: M. A. Babaev, et al.
Published: (2017-03-01)